Post-marketing Safety Surveillance of Qizhi Tongluo Capsules:a Registry Study.

Zhong Wang

Status: Enrolling

Conditions: Adverse Drug Events; Severe Adverse Reactions; Safety Surveillance; Severe Adverse Events; Adverse Drug Reactions

Treatments: Drug: Qizhi Tongluo Capsules

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT04479553

QZTL-V1.0

Details and patient eligibility

About

This registry aims to monitor the safety of Qizhi Tongluo Capsules and to identify the potential risk factors for its adverse drug reactions.

Enrollment: 30,000 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients who use Qizhi Tongluo Capsules in the monitoring hospitals.

Exclusion criteria

• None

Trial design

30,000 participants in 1 patient group

Qizhi Tongluo Capsules

Description:

Qizhi Tongluo Capsules will be given to the patients, and the investigators will record all the information including ADR, application of Qizhi Tongluo Capsules and the combined medications, etc.

Treatment:

Drug: Qizhi Tongluo Capsules